Stayble Therapeutics AB (publ)

OM:STABL Stock Report

Market Cap: SEK 23.0m

Stayble Therapeutics Management

Management criteria checks 2/4

Stayble Therapeutics' CEO is Andreas Gerward, appointed in Jan 2015, has a tenure of 9.83 years. directly owns 1.19% of the company’s shares, worth SEK273.00K. The average tenure of the management team and the board of directors is 8.8 years and 3.5 years respectively.

Key information

Andreas Gerward

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure9.8yrs
CEO ownership1.2%
Management average tenure8.8yrs
Board average tenure3.5yrs

Recent management updates

Recent updates

CEO

Andreas Gerward (36 yo)

9.8yrs

Tenure

Mr. Andreas Gerward, M.Sc., is the Co-Founder and Chief Executive Officer of Stayble Therapeutics AB (publ) since 2015. Mr. Gerward joined Stayble Therapeutics AB in 2014. He has worked with pharmaceutical...

Leadership Team

NamePositionTenureCompensationOwnership
Andreas Gerward
Co-Founder & CEO9.8yrsno data1.19%
SEK 273.0k
Mattias Munnich
Co-Founder7.8yrsno datano data
Erik Kullgren
Chief Financial Officerless than a yearno datano data
Anders Lehmann
Chief Scientific Officer9.8yrsno datano data

8.8yrs

Average Tenure

45yo

Average Age

Experienced Management: STABL's management team is seasoned and experienced (8.8 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Ulf Bjorklund
Chairman of the Board3.4yrsSEK 215.68kno data
Douglas Beall
Member of Scientific Advisory Board3.8yrsno datano data
Erik Kinnman
Director4.4yrsSEK 101.50kno data
Hans Meisel
Member of Scientific Advisory Board3.7yrsno datano data
Jane Laursen
Independent Director6.8yrsSEK 101.50kno data
Björn Strömqvist
Member of Scientific Advisory Boardno datano datano data
Gudrun Anstren
Independent Director3.4yrsSEK 101.50kno data
Gunnar Fernstrom
Independent Director3.4yrsSEK 101.50kno data
Daisuke Sakai
Member of Scientific Advisory Board1.3yrsno datano data

3.5yrs

Average Tenure

68yo

Average Age

Experienced Board: STABL's board of directors are considered experienced (3.5 years average tenure).